Skip to main content
Pure Biologics S.A. logo

Pure Biologics S.A. — Investor Relations & Filings

Ticker · PUR ISIN · PLPRBLG00010 LEI · 2594002TXS19AUYHIF82 WAR Manufacturing
Open in API
Filings indexed 511 across all filing types
Latest filing 2025-10-22 Share Issue/Capital Cha…
Country PL Poland
Listing WAR PUR

About Pure Biologics S.A.

https://purebiologics.com/

Pure Biologics S.A. is a biopharmaceutical company engaged in the discovery and development of novel biological drugs and non-systemic therapies. The company leverages its expertise in antibody and aptamer technologies to create innovative treatments. Its therapeutic portfolio is primarily focused on immuno-oncology. A key aspect of its strategy is the development of original, non-generic and non-biosimilar, biological drug candidates.

Recent filings

Filing Released Lang Actions
Podjęcie przez Zarząd Spółki uchwały w sprawie ustalenia ceny emisyjnej oraz harmonogramu oferty Akcji Serii P2 - Content (PL)
Share Issue/Capital Change Classification · 100% confidence The document is an announcement from Pure Biologics S.A. regarding the issuance of new shares (Series P2), setting the issue price, and defining the timeline for the public offering and subscription period. This falls under the category of share issuance and capital changes.
2025-10-22 Polish
Lista akcjonariuszy posiadających co najmniej 5% głosów na Nadzwyczajnym Walnym Zgromadzeniu Pure Biologics S.A. 21 października 2025 r. - Content (PL)
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document provides a list of shareholders who held at least 5% of the voting rights at the Extraordinary General Meeting (NWZ) of Pure Biologics S.A. This is a formal disclosure of voting results and shareholder participation at a general meeting, which falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2025-10-21 Polish
Treść uchwał podjętych przez NWZ Pure Biologics S.A. w dniu 21.10.2025 r.
AGM Information Classification · 100% confidence The document contains the official resolutions (Uchwała) passed during an Extraordinary General Meeting (Nadzwyczajne Walne Zgromadzenie) of Pure Biologics S.A. It details the voting results, the agenda, and specific corporate actions approved, such as a capital increase and share issuance. Since this document records the formal outcomes and resolutions of a shareholder meeting, it is classified as AGM-R (AGM Information/Materials).
2025-10-21 Polish
Treść uchwał podjętych przez Nadzwyczajne Walne Zgromadzenie Pure Biologics S.A. 21 października 2025 r. - Content (PL)
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short announcement from Pure Biologics S.A. regarding the results of an Extraordinary General Meeting (NWZ) held on October 21, 2025. It explicitly states that it is providing the content of the resolutions and the voting breakdown (votes for, against, and abstentions). This matches the definition of a Declaration of Voting Results & Voting Rights Announcement.
2025-10-21 Polish
Zawiadomienie Filip Jeleń
Major Shareholding Notification Classification · 100% confidence The document is a formal notification ('Zawiadomienie') regarding a change in shareholding structure, specifically referencing 'art. 69 ust. 1 lub 2' of the Polish Act on Public Offering. It details the change in the percentage of share capital and voting rights held by a shareholder (Filip Jeleń) in Pure Biologics S.A. following a capital increase. This is a classic major shareholding notification, which falls under the 'Major Shareholding Notification' category.
2025-10-17 Polish
Zawiadomienie ACRX Investments Limited
Major Shareholding Notification Classification · 100% confidence The document is a formal notification ('Zawiadomienie') submitted by a shareholder (ACRX INVESTMENTS LIMITED) regarding a change in their shareholding percentage in the company PURE BIOLOGICS S.A. It explicitly references 'art. 69 ust. 1 lub 2' of the Polish Act on Public Offering, which is the standard regulatory requirement for disclosing major shareholding thresholds. This fits the definition of a Major Shareholding Notification.
2025-10-17 Polish

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.